This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 12/11/2022
Location: Virtual
Subject: Medical Product Supply Chain
FDA Participant/Group: MATTHEW DEFINA; MICHELLE ADAMS; JULIA TIERNEY;
Non FDA Participant/Group: Brian Tyler, Chris Alverson, Gene Cavacini (McKesson);

Event Date: 12/12/2022
Location: Virtual
Subject: Medical Product Supply Chain
FDA Participant/Group: JULIA TIERNEY; PATRIZIA CAVAZZONI; MICHELLE ADAMS; JACQUELINE CORRIGAN CURAY;
Non FDA Participant/Group: Robert Mauch, Steve Collis (AmerisourceBergen);

Event Date: 12/12/2022
Location: Washington, DC
Subject: Synergy 2022: Aligning Science, Health, Business and Technology for the Future
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other invited guests

Event Date: 12/12/2022
Location: Virtual
Subject: Medical Product Supply Chain
FDA Participant/Group: JULIA TIERNEY; JACQUELINE CORRIGAN CURAY; MATTHEW DEFINA; MICHELLE ADAMS;
Non FDA Participant/Group: Craig Cowman, Jason Hollar, Rebecca McGrath (Cardinal Health);

Event Date: 12/13/2022
Location: Virtual
Subject: Medical Product Supply Chain
FDA Participant/Group: JULIA TIERNEY; MICHELLE ADAMS; ERICA JEFFERSON;
Non FDA Participant/Group: Caroline Tillett, Donna Lorenson, Glen Murphy, Joanne Waldstreicher, Kathleen Widmer, Lynne Szczepaniack (Johnson & Johnson);

Event Date: 12/15/2022
Location: Silver Spring, MD
Subject: Type 1 Diabetes Innovations and Therapies
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Juvenile Diabetes Research Foundation

Event Date: 12/15/2022
Location: Virtual
Subject: Clinical Trials Transformation Initiative: Recommendations on Embedding Trials In Clinical Practice
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other registered attendees

Event Date: 12/16/2022
Location: Virtual
Subject: National Academy of Medicine Opioid Collaborative: Data Framework Exploratory Meeting
FDA Participant/Group: MARTA SOKOLOWSKA;
Non FDA Participant/Group: Several members of the National Academy of Medicine, academia, industry, and government

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

Event Date: 12/15/2022
Location: Virtual
Subject: NIH / FDA COVID-19 Research Workshop
FDA Participant/Group: CAMILA SILVA;
Non FDA Participant/Group: Representatives from National Institutes of Health (NIH) and academia

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 12/13/2022
Location: Virtual
Subject: Quality Assurance and Food Safety Magazine Conference; Panel: Food Safety Culture
FDA Participant/Group: CONRAD CHOINIERE; DONALD PRATER;
Non FDA Participant/Group: Several hundred attendees from across the food industry, academia, state, and federal government agencies

Event Date: 12/16/2022
Location: Virtual
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of industry, trade, and retail associations

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 12/13/2022
Location: Virtual
Subject: FDA / International Society for Stem Cell Research Liaison Meeting
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several representatives from the International Society for Stem Cell Research

Event Date: 12/16/2022
Location: Virtual
Subject: COVID Vaccine Communication and Evaluation Network Vaccine Forum: FDA’s Efforts to Advance COVID-19 Vaccine Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and academia stakeholders

Event Date: 12/17/2022
Location: Gaithersburg, MD
Subject: Chinese Biopharmaceutical Association Annual Conference: FDA’s Perspective on the Future of Cell and Gene Therapy
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, government, research, and academia stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 12/16/2022
Location: Virtual
Subject: National Organization for Rare Disorders' Rare Disease Centers of Excellence Program
FDA Participant/Group: KATHRYN CAPANNA; FELIPE AGUEL; BRENDAN O'LEARY; DANIEL CANOS; MICHELLE TARVER;
Non FDA Participant/Group: Karin Hoelzer, Peter Saltonstall, Susan Baker (National Organization for Rare Disorders);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 12/13/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Leah Wilkinson (American Feed Industry Association);

Event Date: 12/16/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: JEANETTE MURPHY;
Non FDA Participant/Group: Dan Fairfield, Michael Seyfert (National Grain and Feed Association);

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event